In vitro studies of molecular events associated with AKAP9 gene expression alteration in tumour cells linked it to the action of proteins such as CDH1 [38], Cdc42 interacting protein 4 [37], and the Wnt/β-Catenin signalling pathway [39]. The gene discussed is TRIP10; the disease is neoplasm.